Aminologics Co.Ltd (074430) — Cash Flow-to-Debt Ratio
Aminologics Co.Ltd (074430) has a Cash Flow-to-Debt Ratio of 0.15x as of March 2026, meaning its operating cash flow of ₩4.62 Billion could theoretically repay 0% of its total liabilities (₩30.52 Billion) in one year. Explore Aminologics Co.Ltd (074430) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aminologics Co.Ltd Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Aminologics Co.Ltd across 13 annual periods. Also explore how large is Aminologics Co.Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Aminologics Co.Ltd (2008–2025)
Year-by-year debt coverage analysis for Aminologics Co.Ltd. For market capitalisation and broader financial context, see market value of Aminologics Co.Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | ₩2.54 Billion | ₩28.18 Billion | ▼ -93.9% |
| 2024 | 1.47x | ₩7.47 Billion | ₩5.09 Billion | ▲ +2288.3% |
| 2023 | -0.07x | ₩-218.15 Million | ₩3.26 Billion | ▼ -105.4% |
| 2022 | 1.25x | ₩5.23 Billion | ₩4.18 Billion | ▲ +682.1% |
| 2021 | 0.16x | ₩935.52 Million | ₩5.85 Billion | ▼ -40.6% |
| 2020 | 0.27x | ₩1.77 Billion | ₩6.57 Billion | ▼ -55.8% |
| 2019 | 0.61x | ₩3.60 Billion | ₩5.92 Billion | ▼ -51.0% |
| 2018 | 1.24x | ₩4.56 Billion | ₩3.67 Billion | ▲ +75.0% |
| 2017 | 0.71x | ₩3.00 Billion | ₩4.23 Billion | ▼ -23.2% |
| 2016 | 0.92x | ₩4.14 Billion | ₩4.48 Billion | ▲ +223.5% |
| 2015 | 0.29x | ₩1.93 Billion | ₩6.75 Billion | ▲ +193.8% |
| 2014 | -0.30x | ₩-2.07 Billion | ₩6.78 Billion | ▼ -134.4% |
| 2008 | 0.89x | ₩12.19 Billion | ₩13.77 Billion | — |